ArticleFrontiers in psychiatry2026
Empowerment-based case management for treatment-resistant schizophrenia: a three-year single case report.
Article in Frontiers in psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This case report describes the implementation and observed outcomes of an empowerment-oriented case management approach in a patient with treatment-resistant schizophrenia (TRS), addressing the limitations of conventional approaches that often neglect patient autonomy and subjective agency. Through the implementation of a multidisciplinary, four-dimensional empowerment framework-comprising pathological treatment, psychological cognition, social engagement, and family care-a 34-year-old male TRS patient received targeted intervention over a three-year period. Quantitative assessments, including PANSS, HRSD, SDSS, CGI, MRSS, and FAES II-CV, demonstrated substantial improvements: PANSS total score decreased from 90 to 61, CGI severity score reduced from 6 to 3, and MRSS dependency subscale declined from 29 to 14. Qualitative interviews further revealed enhanced medication adherence, symptom self-monitoring, and social functioning, alongside increased daily autonomy, reduced stigma, and improved family dynamics. These preliminary observations from a single case suggest potential benefits that warrant systematic investigation through controlled studies. The temporal associations observed between the intervention and improvements cannot establish causality but provide hypotheses for future research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.